China Electric Vehicle Industry Report, 2013
Published Date » 2013-05-09
No. Of Pages » 88
By 2012, 25 pilot cities had promoted 27,432 new energy vehicles totally within two years after the subsidy policy was implemented, including 23,032 ones used in public services and 4,400 ones bought by individuals.
In March, 2013, the Ministry of Finance, the Ministry of Science and Technology, the Ministry of Industry and Information Technology and Development and Reform Commission reached a consensus, determining to prolong the new energy vehicle subsidy policy by three years. The new subsidy policy emphasizes two aspects: First, it expands the scope of pilot cities; second, it plans to support energy-saving hybrid models with more subsidies. In addition, the new subsidy policy unifies the subsidies of all regions and changes the situation that subsidies vary from region to region.
As new energy vehicles are demonstrated and popularized as well as individuals enjoy subsidies when purchasing new energy vehicles, the domestic output of electric vehicles still maintains a rapid growth. According to the Ministry of Industry and Information Technology, the output of 628 models included in Directory of Recommended Models of Energy-saving and New Energy Vehicles for Demonstration and Application hit 24,800 in 2012, up 94% year on year, of which there were 14,700 passenger cars and more than 10,000 commercial vehicles; there were 13,300 pure electric vehicles, 10,400 conventional hybrid vehicles, and more than 1,000 plug-in hybrid vehicles.
The report analyzes the industrial environments and market of electric vehicles, main demonstration cities, and major production enterprises. Besides, it studies the models contained in the demonstration and promotion directory released by the Ministry of Industry and Information Technology (As of April 2013, there had been 44 batches).
Anhui JAC Co., Ltd. is one of the first companies that are engaged in research and development of new energy vehicles in China. In 2009, JAC clarified that it targeted "pure electric vehicles”. In 2010 and 2011, JAC popularized 1,585 pure electric vehicles. As of the end of 2012, JAC had built a production line with an annual capacity of 20,000 electric vehicles. In accordance with the development plan, the company's annual electric vehicle capacity will reach 100,000 by 2015, and the models will extend from sedans to SUV, special vehicles and buses.
Anhui Ankai Automobile Co., Ltd. is a listed company designated by China to produce luxury buses. As of April 2013, Ankai's 44 hybrid and pure electric models had been incorporated in Directory of Recommended Models of Energy-saving and New Energy Vehicles for Demonstration and Application. It acts as one of leading players in the domestic new energy bus field. As of the end of 2012, Ankai had boasted over 1,000 new energy buses, which run in 27 cities including Beijing, Shanghai, Dalian and Hefei.
Table of Content
1. Overview of China Electric Vehicle Industry
1.1 Introduction and Classification of Electric Vehicle
1.1.3 Technology Roadmap
1.2 Industry Chain
2 Chinese Policy on Electric Vehicle
2.1 Major Policies
2.1.1 Fiscal Subsidies Policy
2.1.2 Demonstration and Promotion Policy
2.1.3 Other Favorable Policies
2.2 Planning of Electric Vehicle Industry
2.2.1 Industry Planning
2.2.2 Technology Development Planning
2.2.3 Charging Station Planning
3 Regional Pattern of Electric Vehicle Industry in China
3.1 Development in Main Regions
3.2.1 Status Quo
3.2.2 Development Planning
3.3.1 Status Quo
3.3.2 Development Planning
3.4.1 Status Quo
3.4.2 Development Planning
3.5.1 Status Quo
3.5.2 Development Planning
3.6.1 Status Quo
3.6.2 Development Planning
3.7.1 Status Quo
3.7.2 Development Planning
3.8.1 Status Quo
3.8.2 Marketing Planning
3.9.1 Status Quo
3.9.2 Development Planning
3.10.1 Status Quo
3.10.2 Development Planning
3.11.1 Status Quo
3.11.2 Development Planning
3.12.1 Status Quo
3.12.2 Development Planning
3.13.1 Status Quo
3.13.2 Development Planning
3.14.1 Status Quo
3.14.2 Development Planning
3.15.1 Status Quo
3.15.2 Development Planning
3.16.1 Status Quo
3.16.2 Development Planning
3.17.1 Status Quo
3.17.2 Development Planning
3.18.1 Status Quo
3.18.2 Development Planning
3.19.1 Status Quo
3.19.2 Development Planning
3.20.1 Status Quo
3.20.2 Development Planning
4 Chinese Electric Vehicle Market
4.1 Market Size
4.2 Market Pattern
4.3 Electric Passenger Car
4.3.1 Market Pattern
4.3.2 Market Size
4.3.3 Major Companies
4.4 Electric Bus
4.4.2 Market Size
4.4.3 Major Companies
5 Key Electric Vehicle Companies in China
5.1 SAIC Motor
5.1.3 Electric Vehicle Business
5.2.3 Electric Vehicle Business
5.3 Dongfeng Motor Corporation
5.3.3 Electric Vehicle Business
5.4.3 Electric Vehicle Business
5.5 Changan Automobile
5.5.3 Electric Vehicle Business
5.6 Chery Automobile
5.6.3 Electric Vehicle Business
5.7.3 Electric Vehicle Business
5.8 Beijing Automotive Group Co.,Ltd (BAIC Group)
5.8.3 Electric Vehicle Business
5.9.3 Electric Vehicle Business
5.10.3 Electric Vehicle Business
5.11 Xiamen King Long Motor Group Co.,Ltd.
5.11.3 Electric Vehicle Business
5.12 Zhongtong Bus
5.12.3 Electric Vehicle Business
5.13 Yutong Group
5.13.3 Electric Vehicle Business
5.14 Yangzhou Yaxing Motor Coach Co., Ltd.
5.14.3 Electric Vehicle Business
List of TablesNA
List of FiguresNA
AFP Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Alpha-fetoprotein (AFP) is the most widely found plasma protein in human fetus. The AFP protein found in humans is encoded by the AFP gene that is located on chromosome 4. It is a major plasma protein which is produced during fetal development in yolk sac and the liver. AFP is a glycoprotein which is found in monomeric, dimeric and trimeric forms. The protein is normally made by immature liver cells in the fetus therefore; infants have higher levels of AFP, which falls to normal adult level by the end of first year. Usually, low level of AFP protein is...
Regenerative Medicine Market (Bone and Joint Applications) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Regenerative medicine is an interdisciplinary field which deals with tissue engineering and cell therapy for replacement or regeneration of human cells/tissue/organ function that may have been damaged due to age, disease, trauma or congenital defects. The research in stem cells (embryonic and adult stem cells) has enabled the applications of regenerative medicine in dentistry, dermatology, neurology and orthopedics. The products developed for applications in bone and joint diseases using regenerative medicine include osteobiologics, bone grafts, allografts, cell-based bone graft...
Age-Related Macular Degeneration (AMD) Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Macular degenerationtherapeutics are used to treat age-related macular degeneration (AMD), a chronic eye disease mostly observed in patient above the age of 50 years.AMD is more prevalent in developed nations and accounts for 8.7 percent of blindness in the world. AMD involves damage to macular areas which impairs the vision of an individual in the center of the retina. Age-related macular degeneration is of two kinds – wet macular degeneration and dry macular degeneration.The former type of AMD is more severe and involves abnormal growth of blood vessels in the macular area damaging...
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Select License type:
- Chinese Home Appliance Industry and Market, February 2014
- Worldwide Desktop PC Forecast, 2014 - 2018
- Worldwide Tablet TFT-LCD Panel Industry, 1Q 2014
- Worldwide Motherboard Forecast, 2014 - 2018
- Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)
- The US Hybrid Vehicles Market Outlook to 2018 - Government Strategy and Cost Effective Hybrids to Escalate Demand
- Philippines Express Delivery and Logistics Market Outlook to 2017 - Maturing Market Sustained by Surging E-Commerce Activity
- France Car Rental Industry Analysis to 2017 - Impelled by Rising Leisure Travel
- India Used Car Industry Outlook to 2018 - Shifting Focus of Key Automakers on Used Car Business
- Europe Car Rental Industry Analysis to 2017 - Latvia, Belgium and Ukraine to Stimulate the Market Growth
Scientists Identify Cure for Dengue
Apr 18, 2014
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year. Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai. The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis. Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods. This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015. Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses. This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...